JCN Network - Home
JCN Newswire
 Search:    Companies  | Annual Reports  |  CSR  | News Alerts  |  Japanese   
Company
News Sectors
Automotive
Chemicals
Consumers
CSR
Electronics
Energy
Environment
Financial
Health & Med
Industrial
IT & Internet
Materials
Real Estate
Science & Tech
Telecoms
Trade
Transportation
Departments
Annual Reports
Companies
Trade Shows
News Alerts
News Search
Photo Gallery
Japan Corporate News Network
About JCN
Privacy Policy
RSS  
Terms of Use
 
Bookmark and Share
Rohto Pharmaceutical Survey Reveals Women Realize Skin Aging in 5-year Cycle
 

Tokyo, Mar 11, 2005 (JCN) - Rohto Pharmaceutical (TSE: 4527) announced on March 10 the results of its latest survey on women and skin conditions. The company conducted an Internet survey of 1,142 women aged 25 to 59, and 771 women interested in anti-aging.

Most of the respondents answered that they tend to realize the skin senescence every five years. Of them, 96.6% admitted that they are interested in anti-aging. Of such respondents, the majority have great interest.

By age, women in their late 20s are mainly concerned about pore-enlargement, dry skin and dullness, those in their 30s or later are worried about care blemish and wrinkles. Skin slackness emerges as another concern among women in their late 30s.

More than 50% of the respondents pointed out the lack of skin care, sunburns and stress as the causes of senescence, and about 70% combat with skin senescence by proactively taking countermeasures such as anti-aging skin care products or supplements.


By Aki Tsukioka Contributor

Copyright © 2010 JCN. All rights reserved. A division of Japan Corporate News Network KK.


 Company Profile |   Print  |   Alerts
ACN Newswire

 Recent  Rohto Pharmaceutical Co., Ltd. News  RSS  
  Rohto Pharmaceuticals New Powder Drink Mix That Nurtures Strong Bones  (Apr 18, 2007)
  Rohto Pharmaceutical, Dynamics Therapeutics Enter into Licensing Agreement for Anti-aging Ingredient Supplamine  (June 8, 2006)
  Rohto Pharmaceutical to Introduce Platinum Nanocolloid-based Cosmetic Products in July  (May 19, 2006)
  Rohto Pharmaceutical Sets Up New Research Base in Kyoto  (May 13, 2006)
  Rohto Pharmaceutical Confirms That Vitamin Medication Containing Sedative Crude Drug Helps Improve Sleep Quality  (Apr 28, 2006)
  Rohto Pharmaceutical to Open Real-time Pollen Dispersal Forecast Website  (Jan 17, 2006)
  Rohto Pharmaceutical Joins Hands with Pharma Foods International  (Sept 21, 2005)
  Rohto Pharmaceutical to Acquire Bayer Yakuhin's Research Center in Kyoto  (Aug 3, 2005)
  Rohto Pharmaceutical and Nichi Nichi Pharmaceutical Confirm that Lactic Acid Bacteria Preparation LFK Helps Inhibit Skin Pigmentation and Whiten Skin  (June 9, 2005)
  Rohto Pharmaceutical, LTT Bio-Pharma Develops World's First Retinol-contaning Nanocapsule  (Apr 7, 2005)



 Recent  Health/Medical News   RSS  
Asahi Kasei Integrates Bioprocess Businesses in North America (Dec 31, 2009)
Asahi Kasei Kuraray Medical Establishes Sales Subsidiary in Korea (Nov 1, 2009)
Asahi Kasei Launches 'Reveal DX' Insertable Cardiac Monitor (Oct 1, 2009)
New RIKEN Robot to Assist in Care Facilities (Sept 29, 2009)
Asahi Kasei Kuraray Medical Building Plant for Therapeutic Apheresis Devices (Sept 25, 2009)
Teijin Develops World's First Bioplastic Eyeglasses (Sept 4, 2009)
Astellas Establishes Fund Laboratory 'Genome Medical Science Laboratory' at the University of Tokyo (Sept 4, 2009)
Kuraray Mediacal Obtains Approval for Artificial Bone Graft (Sept 2, 2009)
Daiichi Sankyo, Ranbaxy Launch Psteoporosis Medication EVISTA in Romania (Sept 2, 2009)
Pfizer and Astellas to Co-promote Hypertension, Hypercholesterolemia Treatment (Aug 31, 2009)

More Health/Medical news...

 Recent  Health/Medical News   RSS  
Asahi Kasei Integrates Bioprocess Businesses in North America (Dec 31, 2009)
Asahi Kasei Kuraray Medical Establishes Sales Subsidiary in Korea (Nov 1, 2009)
Asahi Kasei Launches 'Reveal DX' Insertable Cardiac Monitor (Oct 1, 2009)
New RIKEN Robot to Assist in Care Facilities (Sept 29, 2009)
Asahi Kasei Kuraray Medical Building Plant for Therapeutic Apheresis Devices (Sept 25, 2009)
Teijin Develops World's First Bioplastic Eyeglasses (Sept 4, 2009)
Astellas Establishes Fund Laboratory 'Genome Medical Science Laboratory' at the University of Tokyo (Sept 4, 2009)
Kuraray Mediacal Obtains Approval for Artificial Bone Graft (Sept 2, 2009)
Daiichi Sankyo, Ranbaxy Launch Psteoporosis Medication EVISTA in Romania (Sept 2, 2009)
Pfizer and Astellas to Co-promote Hypertension, Hypercholesterolemia Treatment (Aug 31, 2009)

More Health/Medical news...
 
 
CSR Report Download
Annual Reports

  More >>    
Most Popular


About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)